Lasa Supergenerics to invest ₹50 cr to tackle the virus

The Hindu Business Line
Active Pharmaceutical Ingredients producer Lasa Supergenerics is looking at infusing ₹50 crore for developing Favipiravir, an anti-viral drug, which is expected to show positive results…